| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |